CYAD

COM:CELYAD

Celyad Oncology

Add to Watchlist

Stock

0.53 −3.28%

−0.02

EUR last updated 01/04 01:29:30

Last Close

0.55

31/03 15:35

Market Cap

11.14M

Beta: -

Volume Today

13.66K

Avg: -

Overview Metrics Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
revenue	146K -	3K 97.95%	8.52M 284,000%	3.54M 58.47%	3.12M 12.01%	6K 99.81%	5K 16.67%			102K -
cost of revenue	115K -	6.38M 5,449.57%	53K 99.17%	515K 871.70%						69K -
gross profit	31K -	-6.38M 20,677.42%	8.47M 232.78%	3.02M 64.29%	3.12M 2.98%	6K 99.81%	5K 16.67%			33K -
selling and marketing expenses	394K -	891K 126.14%	728K 18.29%	761K 4.53%	676K 11.17%	607K 10.21%	454K 25.21%
general and administrative expenses	5.02M -	7.23M 44.14%	9.74M 34.77%	9.31M 4.45%	10.39M 11.57%	8.72M 16.00%	8.99M 3.09%	9.66M 7.45%	10.34M 6.95%
selling general and administrative expenses	5.02M -	7.23M 44.14%	9.74M 34.77%	9.31M 4.45%	10.39M 11.57%	8.72M 16.00%	8.99M 3.09%	9.66M 7.45%	10.34M 6.95%	6.03M 41.69%
research and development expenses	15.87M -	5.90M 62.82%	27.68M 369.15%	22.91M 17.22%	23.58M 2.92%	25.23M 7.02%	21.59M 14.43%	20.77M 3.79%	18.93M 8.88%	4.60M 75.69%
other expenses	-963K -	-222K 76.95%	-2.52M 1,036.49%	-23.79M 843.00%	7.32M 130.77%	-4.58M 162.53%	-4.34M 5.16%	-3.53M 18.72%	-9.00M 155.09%
cost and expenses	20.03M -	29.68M 48.13%	34.13M 15.02%	30.14M 11.69%	41.28M 36.96%	29.38M 28.84%	26.24M 10.67%	26.91M 2.53%	20.26M 24.70%	10.70M 47.20%
operating expenses	19.92M -	29.68M 48.99%	34.08M 14.84%	29.63M 13.06%	41.28M 39.34%	29.38M 28.84%	26.24M 10.67%	26.91M 2.53%	20.26M 24.70%	10.63M 47.54%
interest expense	22K -	236K 972.73%	207K 12.29%	4.45M 2,051.69%	62K 98.61%	343K 453.23%	297K 13.41%	255K 14.14%	197K 22.75%	84K 57.36%
ebitda	-18.04M -	-27.84M 54.32%	-21.89M 21.39%	-16.66M 23.87%	-37.37M 124.21%	-27.45M 26.54%	-24.19M 11.87%	-25.58M 5.73%	-18.81M 26.46%	-10.60M 43.67%
operating income	-16.44M -	-29.67M 80.52%	-25.61M 13.69%	-52.88M 106.47%	-38.17M 27.81%	-29.37M 23.05%	-26.24M 10.67%	-26.39M 0.58%	-40.86M 54.81%	-10.60M 74.06%
depreciation and amortization	870K -	1.03M 18.74%	1.52M 46.76%	9.00M 493.93%	805K 91.06%	1.92M 138.88%	2.05M 6.45%	813K 60.28%	22.05M 2,611.69%
total other income expenses net	3.18M -	252K 92.07%	1.34M 430.56%	-26.27M 2,065.07%	743K 102.83%	733K 1.35%	9.04M 1,132.61%	-111K 101.23%	-13K 88.29%	2.09M 16,146.15%
income before tax	-16.45M -	-29.11M 76.95%	-23.61M 18.90%	-56.40M 138.84%	-37.43M 33.64%	-28.64M 23.48%	-17.20M 39.93%	-26.50M 54.05%	-40.87M 54.21%	-8.51M 79.18%
income tax expense	-2.48M -	-55K 97.78%	-6K 89.09%	-1K 83.33%	-1.11M 111,300%	-8K 99.28%	297K 3,812.50%	10K 96.63%	65K 550%	-63K 196.92%
net income	-16.45M -	-29.11M 76.95%	-23.61M 18.92%	-56.40M 138.90%	-36.31M 35.61%	-28.63M 21.15%	-17.50M 38.88%	-26.51M 51.49%	-40.94M 54.40%	-8.45M 79.36%
weighted average shs out	6.75M -	8.48M 25.65%	9.31M 9.81%	9.62M 3.33%	11.14M 15.75%	12.52M 12.43%	13.94M 11.33%	15.60M 11.92%	22.59M 44.80%
weighted average shs out dil	6.75M -	8.49M 25.74%	9.33M 9.92%	9.62M 3.14%	11.14M 15.75%	12.52M 12.43%	13.94M 11.33%	15.60M 11.92%	22.59M 44.80%
eps	-2.44 -	-3.43 40.57%	-2.53 26.24%	-5.86 131.62%	-3.26 44.37%	-2.29 29.75%	-1.26 44.98%	-1.70 34.92%	-1.81 6.47%	-0.33 81.77%
epsdiluted	-2.44 -	-3.43 40.57%	-2.53 26.24%	-5.86 131.62%	-3.26 44.37%	-2.29 29.75%	-1.26 44.98%	-1.70 34.92%	-1.81 6.47%	-0.33 81.77%

All numbers in EUR (except ratios and percentages)